Västra Hamnen Market Focus Feed

2023-03-16 08:30:00 Bioextrax: Advancing the green transition

2023-03-08 08:30:00 Medimi: Initierar pilotprojekt i Finland

2023-03-07 08:30:00 Promore Pharma: Histopatologisk analys i slutfas

2023-03-03 14:15:00 Chordate: Levererar enligt sin strategiska plan

2023-02-23 08:30:00 Crunchfish: A reassessment of assumptions

2023-02-22 09:30:00 ProstaLund: Intressanta framtidsutsikter

2023-02-22 08:30:00 ProstaLund: Intressanta framtidsutsikter

2022-12-08 08:30:00 Promore Pharma: Inväntar resultat

2022-11-21 10:30:00 Västra Hamnen Corporate Finance publishes an updated equity analysis on Crunchfish

2022-11-21 08:30:00 Crunchfish: Fishing for bigger deals

2022-11-14 08:30:00 Magle Chemoswed: Targeting profitability

2022-11-09 09:00:00 Movinn: Impressive unit growth continues

2022-11-02 09:00:00 USWE: Synergy effects starting to emerge

2022-10-26 10:30:00 ProstaLund: Flyttar fram positionen i Europa

2022-09-09 15:30:00 Movinn: Growing domestically and abroad

2022-09-06 09:00:00 Chordate: Tyskt delresultat stundar

2022-09-01 16:10:00 Promore Pharma: Utvecklingsarbetet fortlöper

2022-08-29 16:30:00 Crunchfish: Moving forward

2022-08-23 16:15:00 Heliospectra: Executing operational changes

2022-08-19 11:20:00 Magle Chemoswed: Delivering healthy sales

2022-08-05 16:30:00 USWE: Another acquisition announced

2022-06-20 10:00:00 Invitation to ViroGates’ investor meeting

2022-06-03 10:23:00 USWE: Sales dip due to supply issues

2022-06-01 14:29:00 Chordate: Nya studier aviseras

2022-05-19 14:20:00 Crunchfish: Central banks calling

2022-05-18 15:27:00 Promore Pharma: Ärrstudie fullrekryterad

2022-05-12 13:32:00 Magle Chemoswed: Strong margins due to mix

2022-05-12 10:35:00 Movinn: Meeting expectations

2022-05-10 11:24:00 ViroGates: Healthy growth

2022-05-10 10:57:00 ProstaLund: Fler strängar på lyran

2022-05-03 12:10:00 Medimi: Pandemipåverkan avtar

2022-05-03 09:30:00 Invitation to ViroGates’ Q1 2022 presentation

2022-04-27 09:27:00 Heliospectra: In transition

2022-04-05 17:00:00 Movinn: Moving abroad

2022-03-31 14:00:00 Västra Hamnen Corporate Finance publishes an updated equity analysis on Crunchfish

2022-03-31 14:00:00 Crunchfish: Business model crystalizing

2022-03-25 11:09:00 ViroGates: Growing customer base

2022-03-21 12:05:00 Invitation to ViroGates’ Full Year 2021 presentation

2022-03-04 11:07:00 Magle Chemoswed: Resilience amid royalty dip

2022-03-03 15:10:00 Heliospectra: Strategic shift afoot

2022-03-01 14:00:00 Chordate: Tar steget in i Storbritannien

2022-02-23 10:15:00 ProstaLund: Lägger grunden utomlands

2022-02-22 10:20:00 USWE: Continues to impress

2022-02-18 12:22:00 Crunchfish: Platform strategy implemented

2022-02-18 09:23:00 Clemondo: Greenium visar sin styrka

2022-02-17 10:25:00 Promore Pharma: Första patient i ärrstudie

2022-02-11 11:46:00 Medimi: Omikron stal momentum

2021-12-17 13:17:00 ViroGates on positive EMA opinion regarding suPAR-guided anakinra treatment (Video)

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Västra Hamnen Market Focus

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden